These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 28202625)

  • 21. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
    Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
    Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
    Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers.
    Pallozzi M; De Gaetano V; Di Tommaso N; Cerrito L; Santopaolo F; Stella L; Gasbarrini A; Ponziani FR
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
    Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
    BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbiota, NASH, HCC and the potential role of probiotics.
    Brandi G; De Lorenzo S; Candela M; Pantaleo MA; Bellentani S; Tovoli F; Saccoccio G; Biasco G
    Carcinogenesis; 2017 Mar; 38(3):231-240. PubMed ID: 28426878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma.
    Jia W; Rajani C; Xu H; Zheng X
    Protein Cell; 2021 May; 12(5):374-393. PubMed ID: 32797354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2.
    Xu Y; Zhao W; Xu J; Li J; Hong Z; Yin Z; Wang X
    Oncotarget; 2016 Feb; 7(8):8866-78. PubMed ID: 26758420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice.
    Yamada S; Takashina Y; Watanabe M; Nagamine R; Saito Y; Kamada N; Saito H
    Oncotarget; 2018 Feb; 9(11):9925-9939. PubMed ID: 29515780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma.
    Sun H; Yang W; Tian Y; Zeng X; Zhou J; Mok MTS; Tang W; Feng Y; Xu L; Chan AWH; Tong JH; Cheung YS; Lai PBS; Wang HKS; Tsang SW; Chow KL; Hu M; Liu R; Huang L; Yang B; Yang P; To KF; Sung JJY; Wong GLH; Wong VWS; Cheng ASL
    Nat Commun; 2018 Dec; 9(1):5214. PubMed ID: 30523261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
    Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
    Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment.
    Schneider KM; Mohs A; Gui W; Galvez EJC; Candels LS; Hoenicke L; Muthukumarasamy U; Holland CH; Elfers C; Kilic K; Schneider CV; Schierwagen R; Strnad P; Wirtz TH; Marschall HU; Latz E; Lelouvier B; Saez-Rodriguez J; de Vos W; Strowig T; Trebicka J; Trautwein C
    Nat Commun; 2022 Jul; 13(1):3964. PubMed ID: 35803930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gut microbiome and liver cancer: mechanisms and clinical translation.
    Yu LX; Schwabe RF
    Nat Rev Gastroenterol Hepatol; 2017 Sep; 14(9):527-539. PubMed ID: 28676707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
    Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
    Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond.
    Ohtani N; Kamiya T; Kawada N
    Hepatol Commun; 2023 Sep; 7(9):. PubMed ID: 37639702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut-derived lipopolysaccharide promotes T-cell-mediated hepatitis in mice through Toll-like receptor 4.
    Lin Y; Yu LX; Yan HX; Yang W; Tang L; Zhang HL; Liu Q; Zou SS; He YQ; Wang C; Wu MC; Wang HY
    Cancer Prev Res (Phila); 2012 Sep; 5(9):1090-102. PubMed ID: 22617167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma.
    Fatima N; Akhtar T; Sheikh N
    Can J Gastroenterol Hepatol; 2017; 2017():6238106. PubMed ID: 28573132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor immunostimulatory activity of polysaccharides from Salvia chinensis Benth.
    Shu G; Zhao W; Yue L; Su H; Xiang M
    J Ethnopharmacol; 2015 Jun; 168():237-47. PubMed ID: 25858511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
    Carloni V; Luong TV; Rombouts K
    Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO.
    Li T; Yang Y; Hua X; Wang G; Liu W; Jia C; Tai Y; Zhang Q; Chen G
    Cancer Lett; 2012 May; 318(2):154-61. PubMed ID: 22182446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.